ABSTRACT
Morbidity and mortality for patients on ECMO is high, presenting an additional set of challenges for patients, families, and caregivers. B Introduction: b Extracorporeal membrane oxygenation (ECMO) is instituted for patients with COVID-19 in severe circulatory or respiratory failure as bridge to recovery or destination therapies (device implantation or organ transplantation). [Extracted from the article] Copyright of Critical Care Medicine is the property of Lippincott Williams & Wilkins and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)